YOSHIO YAMAOKA to Follow-Up Studies
This is a "connection" page, showing publications YOSHIO YAMAOKA has written about Follow-Up Studies.
Connection Strength
0.326
-
Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). PLoS One. 2021; 16(8):e0255601.
Score: 0.092
-
Prevalence and Antibiotic Resistance Patterns of Helicobacter pylori Infection in Koh Kong, Cambodia. Asian Pac J Cancer Prev. 2020 May 01; 21(5):1409-1413.
Score: 0.084
-
Efficacy of Omeprazole, Tetracycline, and 4 Times Daily Dosing of Amoxicillin in Helicobacter pylori Eradication in Limited Resource Area in Bhutan: A Prospective Randomized Trial (BHUTAN Study). Asian Pac J Cancer Prev. 2020 Apr 01; 21(4):1109-1114.
Score: 0.084
-
CYP2C19 Genotype, CagA Genotype and Antibiotic Resistant
Strain of Helicobacter pylori Infection Asian Pac J Cancer Prev. 2019 Apr 29; 20(4):1243-1247.
Score: 0.020
-
Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol. 2018 Jan; 33(1):37-56.
Score: 0.018
-
Virulence genes of Helicobacter pylori in gastritis, peptic ulcer and gastric cancer in Laos. Asian Pac J Cancer Prev. 2014; 15(20):9027-31.
Score: 0.014
-
A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol. 2005 Nov; 100(11):2387-92.
Score: 0.008
-
Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004 Sep; 53(9):1235-43.
Score: 0.007